Acasă › Boala Crohn › Colorado
Studii clinice pentru Boala Crohn în Colorado
18 studii pentru Boala Crohn caută participanți în Colorado.
Orașe în Colorado
Text oficial al studiului (în engleză)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026), Aurora
- Peak Gastroenterology Associates ( Site 5023), Colorado Springs
- South Denver Gastroenterology, PC ( Site 5132), Englewood
- și încă 1
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Peak Gastroenterology Associates, Colorado Springs
- Rocky Mountain Endocopy Centers LLC, Littleton
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 265557, Colorado Springs
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07196722An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- UCHealth Digestive Health Center - Anschutz Medical Campus-Site Number: 8400085, Aurora
- Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado Springs
- Gastroenterology of the Rockies - Denver-Site Number: 8400122, Denver
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado Springs
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Children's Hospital Colorado - Aurora /ID# 255764, Aurora
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 23 sept. 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates - Colorado Springs, Colorado Springs
În curs de recrutareFaza 2
Vârste de la 18 la 85 · Toate sexele · Actualizat 22 sept. 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- South Denver Gastroenterology, Englewood
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- South Denver Gastroenterology, Englewood
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07483099A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT07577843Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Colorado, Aurora
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 7 aug. 2026 · NCT05230173Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Children's Hospital Colorado - Aurora /ID# 262207, Aurora
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 24 iun. 2026 · NCT06332534A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
În curs de recrutareFaza 3
Vârste de la 18 la 65 · Toate sexele · Actualizat 27 mai 2026 · NCT06227910Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Peak Gastroenterology Associates, Colorado Springs
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 27 apr. 2026 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Colorado Springs
- Mirador Therapeutics Selected Site, Littleton
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 12 mar. 2026 · NCT07113522Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.